The luxury metaphor of alcoholic beverages marketing: a necessary focus and understanding to help public healthDIOUF, Jacques François.Journal de gestion et d'économie médicales. 2014, Vol 32, Num 3, pp 209-225, issn 2262-5305, 17 p.Article

Les médecins grands et beaux sont-ils plus souvent perçus comme de « grands » médecins ? = ARE TALLAND GOOD-LOOKING DOCTORS MORE OFTEN PERCEIVED AS GREAT DOCTORS?MACE, Serge; WOLFF, François-Charles.Journal de gestion et d'économie médicales. 2014, Vol 32, Num 4, pp 245-262, issn 2262-5305, 18 p.Article

A Review of the Psychometric Properties of Generic Utility Measures in Multiple SclerosisKUSPINAR, Ayse; MAYO, Nancy E.PharmacoEconomics (Auckland). 2014, Vol 32, Num 8, pp 759-773, issn 1170-7690, 15 p.Article

Assessing the Value of Healthcare Interventions Using Multi-Criteria Decision Analysis: A Review of the LiteratureMARSH, Kevin; LANITIS, Tereza; NEASHAM, David et al.PharmacoEconomics (Auckland). 2014, Vol 32, Num 4, pp 345-365, issn 1170-7690, 21 p.Article

Barriers to the Uptake of Biosimilars and Possible Solutions: A Belgian Case StudyDYLST, Pieter; VULTO, Arnold; SIMOENS, Steven et al.PharmacoEconomics (Auckland). 2014, Vol 32, Num 7, pp 681-691, issn 1170-7690, 11 p.Article

Compensation of Chief Executive Officers at Nonprofit US HospitalsJOYNT, Karen E; LE, Sidney T; ORAV, E. John et al.JAMA internal medicine (Print). 2014, Vol 174, Num 1, pp 61-67, issn 2168-6106, 7 p.Article

Economic Evaluations of Gastroesophageal Reflux Disease Medical ManagementGAWRON, Andrew J; FRENCH, Dustin D; PANDOLFINO, John E et al.PharmacoEconomics (Auckland). 2014, Vol 32, Num 8, pp 745-758, issn 1170-7690, 14 p.Article

How to Estimate Productivity Costs in Economic EvaluationsKROL, Marieke; BROUWER, Werner.PharmacoEconomics (Auckland). 2014, Vol 32, Num 4, pp 335-344, issn 1170-7690, 10 p.Article

Including Adverse Drug Events in Economic Evaluations of Anti-Tumour Necrosis Factor-α Drugs for Adult Rheumatoid Arthritis: A Systematic Review of Economic Decision Analytic ModelsHEATHER, Eleanor M; PAYNE, Katherine; HARRISON, Mark et al.PharmacoEconomics (Auckland). 2014, Vol 32, Num 2, pp 109-134, issn 1170-7690, 26 p.Article

Optimal booking and scheduling in outpatient procedure centersBERG, Bjorn P; DENTON, Brian T; AYCA ERDOGAN, S et al.Computers & operations research. 2014, Vol 50, pp 24-37, issn 0305-0548, 14 p.Article

Scalable approximate policies for Markov decision process models of hospital elective admissionsZHU, George; LIZOTTE, Dan; HOEY, Jesse et al.Artificial intelligence in medicine (Print). 2014, Vol 61, Num 1, pp 21-34, issn 0933-3657, 14 p.Article

Tocilizumab in the Treatment of Rheumatoid Arthritis: A Cost-Effectiveness Analysis in the UKDIAMANTOPOULOS, Alex; FINCKH, A; HUIZINGA, T et al.PharmacoEconomics (Auckland). 2014, Vol 32, Num 8, pp 775-787, issn 1170-7690, 13 p.Article

Treatment Sequencing After Failure of the First Biologic in Cost-Effectiveness Models of Psoriasis: A Systematic Review of Published Models and Clinical Practice GuidelinesMAUSKOPF, Josephine; SAMUEL, Miny; McBRIDE, Doreen et al.PharmacoEconomics (Auckland). 2014, Vol 32, Num 4, pp 395-409, issn 1170-7690, 15 p.Article

Les génériques: des médicaments à soigner ! : Que penser des génériques ? = Generics: drugs to take care of!LECHAT, P.La Lettre du pharmacologue (Boulogne). 2014, Vol 28, Num 2, pp 52-56, issn 0984-452X, 5 p.Article

Some Inconsistencies in NICE's Consideration of Social ValuesPAULDEN, Mike; O'MAHONY, James F; CULYER, Anthony J et al.PharmacoEconomics (Auckland). 2014, Vol 32, Num 11, pp 1043-1053, issn 1170-7690, 11 p.Article

A nonparametric approach to medical survival data: Uncertainty in the context of risk in mortality analysisJANUROVA, Kateřina; BRIS, Radim.Reliability engineering & systems safety. 2014, Vol 125, pp 145-152, issn 0951-8320, 8 p.Article

Health Economic Issues in ChinaWU, Eric Q; SHI, Lizheng; XIE, Jipan et al.PharmacoEconomics (Auckland). 2014, Vol 32, Num 3, issn 1170-7690, 85 p.Serial Issue

Does Economic Incentive Matter for Rational Use of Medicine? China's Experience from the Essential Medicines ProgramMINGSHENG CHEN; LIJIE WANG; WEN CHEN et al.PharmacoEconomics (Auckland). 2014, Vol 32, Num 3, pp 245-255, issn 1170-7690, 11 p.Article

Séminaire de l'étude nationale des coûts à méthodologie communeJournal de gestion et d'économie médicales. 2014, Vol 32, Num 2, issn 2262-5305, 62 p.Conference Proceedings

Facteurs clés de la performance collective de groupements d'achats de produits de santé = KEY DRIVERS TO EVALUATE THE COLLECTIVE PERFORMANCE OF HEALTH PRODUCTS PURCHASING GROUPVINCENT, Béatrice; MONTALAN, Marie-Annick.Journal de gestion et d'économie médicales. 2014, Vol 32, Num 1, pp 11-24, issn 2262-5305, 14 p.Article

Parcours de soins en cancérologie et financement = Cancer treatment process and fundingRAVAUD, Alain.Journal de gestion et d'économie médicales. 2014, Vol 32, Num 2, pp 105-112, issn 2262-5305, 8 p.Conference Paper

A multi-objective grouping Harmony Search algorithm for the optimal distribution of 24-hour medical emergency unitsLANDA-TORRES, I; MANJARRES, D; SALCEDO-SANZ, S et al.Expert systems with applications. 2013, Vol 40, Num 6, pp 2343-2349, issn 0957-4174, 7 p.Article

Analyzing the enabling factors for the organizational decision to adopt healthcare information systemsZHENBIN YANG; KANKANHALLI, Atreyi; NG, Boon-Yuen et al.Decision support systems. 2013, Vol 55, Num 3, pp 764-776, issn 0167-9236, 13 p.Article

Association of potentially inappropriate medication use with patient and prescriber characteristics in Medicare Part DHOLMES, Holly M; RUILI LUO; KUO, Yong-Fang et al.Pharmacoepidemiology and drug safety. 2013, Vol 22, Num 7, pp 728-734, issn 1053-8569, 7 p.Article

1983-2013: les évolutions de la politique de santé = 1983-2013: The evolutions of the health policyTABUTEAU, Didier.Journal de gestion et d'économie médicales. 2013, Vol 31, Num 1, pp 53-68, issn 2262-5305, 16 p.Article